OTTAWA / LOS ANGELES — In this discussion with Chris Meyer of Widefountain, we dig deeper into my findings on an explosive narcotics precursor case quietly dropped by Canadian prosecutors—and what it reveals about Canada’s growing vulnerabilities to foreign infiltration.
We unpack the story of a Chinese chemist, known here as Dr. X, who was charged with importing more than 100 kilograms of PMK ethyl glycidate—a key chemical used in the production of MDMA (ecstasy). Court records show Dr. X had direct ties to a bio-pharmaceutical firm affiliated with the University of British Columbia, and was reportedly recruited under Beijing’s “Thousand Talents Plan”—a program U.S. intelligence agencies warn is used to facilitate espionage and the transfer of dual-use technologies.
